IMIB:LSE:LSE-iShares FTSE MIB UCITS Dist (GBX)

ETF | Others |

Last Closing

USD 2012.75

Change

-42.75 (-2.08)%

Market Cap

N/A

Volume

1.17K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.09 (+0.45%)

USD 640.06B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.05%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

-1.28 (-0.96%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

+0.12 (+0.38%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

+0.50 (+0.70%)

USD 266.08B
0QZO:LSE 0QZO

-1.20 (-1.08%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-7.10 (-4.76%)

USD 202.26B
0R24:LSE Intel Corp.

-0.64 (-3.09%)

USD 196.14B

ETFs Containing IMIB:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.33% 89% A- 84% B
Dividend Return 0.02% 36% F 29% F
Total Return 17.36% 89% A- 84% B
Trailing 12 Months  
Capital Gain 13.59% 83% B 78% C+
Dividend Return 0.04% 29% F 25% F
Total Return 13.64% 82% B 77% C+
Trailing 5 Years  
Capital Gain 116.97% 90% A- 88% B+
Dividend Return 0.31% 36% F 50% F
Total Return 117.28% 88% B+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 12.79% 70% C- 74% C
Dividend Return 12.74% 69% C- 73% C
Total Return -0.04% 2% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 13.96% 50% F 68% D+
Risk Adjusted Return 91.27% 85% B 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.